A process for reducing the tendency of a drug substance to aggregate and/oragglomerate during storage. The processinvolves micronising the drug substance to give a mean particle size of lessthan about 10 µm, and exposing the microniseddrug substance to a dry environment at an elevated temperature between40° C and 120° C for at least six hours.